Quantum BioPharma Ltd.

NASDAQ: QNTM · Real-Time Price · USD
18.14
0.11 (0.61%)
At close: Aug 20, 2025, 3:59 PM

Quantum BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6M 2.76M 16.98M 35.26M
Short-Term Investments
1.2M 756.1K 23.19K 158.04K
Long-Term Investments
2.22K 6.05K 827.61K 660.23K
Other Long-Term Assets
n/a 907.37K 7.43M n/a
Receivables
3.81M 7.42M 374.38K 500.96K
Inventory
117.17K n/a n/a n/a
Other Current Assets
867.86K 63.38K 471.92K 8.65M
Total Current Assets
12.05M 11.09M 17.84M 45.93M
Property-Plant & Equipment
130.38K 119.8K 260.81K 168.31K
Goodwill & Intangibles
4.93M 5.36M 12.04M 16.2M
Total Long-Term Assets
5.07M 6.39M 20.56M 17.03M
Total Assets
17.12M 17.47M 38.41M 62.96M
Account Payables
3.25M 3.24M 2.76M 3M
Deferred Revenue
999.4K n/a n/a n/a
Short-Term Debt
771.14K 300.55K 300.55K 300.55K
Other Current Liabilities
492.6K 31.34K 243.59K 811.43K
Total Current Liabilities
6.68M 4.57M 7.83M 8.7M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 38K 131.04K
Total Liabilities
6.68M 4.57M 7.87M 8.83M
Total Debt
824.92K 339.2K 516.42K 555.9K
Common Stock
150.38M 137.78M 143.35M 152.12M
Retained Earnings
-172.11M -157.91M -144.16M -126.15M
Comprehensive Income
50.8K 417.34K 652.6K 239.61K
Shareholders Equity
11.48M 13.24M 30.54M 54.13M
Total Investments
1.2M 762.15K 850.8K 818.26K